Alliances
Bristol-Myers Squibb is teaming up with Cancer Research UK and the Francis Crick Institute to create guidelines for immuno-oncology therapy development. This “rule book,” will focus on lung cancer treatments.
In the framework of a preferred partnership, Yposkesi plans to grant Axovant access to dedicated cGMP capacity and manufacturing resources to further support the global development and commercialization of Axovant’s AAV-based gene therapy programs
Sensor-based technology aims to provide veterinarians with collection of rapid reference-lab quality tests at the point-of-care
It is anticipated that this initial concept will be scaled to all UK biobanks and genomic cohorts and will be replicated across European countries wanting to adopt the UK model through working with European organisations such as BBMRI-ERIC and ELIXIR.
Aruvant’s pipeline anchored by RVT-1801, an investigational gene therapy for sickle cell disease and β-thalassemia
CBT’s c-Met inhibitor and anti-PD1 antibody to be evaluated in combination with Bossan’s EGFR inhibitor
Abu Dhabi Smart Solutions and Services Authority, in collaboration with the Abu Dhabi Health Services Company (SEHA), organized a seasonal influenza vaccination campaign for its employees as a preventive measure to contain the spread of influenza virus at this time of the year.
COMBINATION OF CUTTING-EDGE IPSC AND AI TECHNOLOGIES CREATES OPPORTUNITY TO DISCOVER NOVEL METABOLIC LIGANDS TO ACCELERATE DRUG DISCOVERY IN RARE METABOLIC DISEASES
Roivant Sciences teamed with Cincinnati Children’s Hospital Medical Center to launch Aruvant Sciences. Roivant is the umbrella company run by Vivek Ramaswamy, which has launched a number of companies with “vant” in the names.
Combined Technologies May Yield Therapies for Multiple Cancer Indications
PRESS RELEASES